Arca Biopharma | ABIO - Frais De Vente Et D'Administration

Prix De L'Action
60.58
Variation Quotidienne
1.00 1.68%
Mensuellement
45.10%
Annuel
644.23%
Q2 Prévisions
57.95




Frais De Vente Et D'Administration Changement Date
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.94B 237M 2025-12
Arca Biopharma USD 2.23M 1.08M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
Otsuka Holdings JPY 278.3B 24.08B 2025-12
Pfizer USD 4.08B 894M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12